University of Cambridge
Roger Barker is the Professor of Clinical Neuroscience at the University of Cambridge and Consultant Neurologist at the Addenbrooke's Hospital Cambridge. He is a PI in the Cambridge Stem Cell Institute in Cambridge and directs the new chair of neurodegeneration at LifeArc. For the last 25 years he has run research that seeks to better define the clinical heterogeneity of two common neurodegenerative disorders of the CNS- namely Parkinson's (PD) and Huntington's disease (HD). This has helped him define the best to take new treatments into the clinic, in particular cell based therapies. He is part of the global initiative (GFORCE-PD) that is seeking to take stem cells to trial in patients with PD and clinical lead of the ongoing STEM PD trial.
BEST PRACTICES FOR THE DEVELOPMENT OF PSC-DERIVED CELLULAR THERAPIES
Thursday, July 11, 2024
8:15 AM – 9:45 AM CEST
Saturday, July 13, 2024
8:15 AM – 9:45 AM CEST
PLENARY VI: THE CLINICAL REALITY AND PROMISE OF CELL AND GENE THERAPIES
Saturday, July 13, 2024
10:00 AM – 11:35 AM CEST